Dr Jose M. Jimenez-Guardeño Research fellows Research Fellow Contact details jose.jimenez@kcl.ac.uk +44 (0) 20 7188 5398
Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein Kcl Test: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2 Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2: Quantum-inspired identification of SARS-CoV-2 antivirals TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation An overview of vaccines against sars-cov-2 in the covid-19 pandemic era MX2-mediated innate immunity against HIV-1 is regulated by serine phosphorylation Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice Immunoproteasome activation enables human TRIM5α restriction of HIV-1 Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction View all publications